<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00111293</url>
  </required_header>
  <id_info>
    <org_study_id>050157</org_study_id>
    <secondary_id>05-M-0157</secondary_id>
    <nct_id>NCT00111293</nct_id>
  </id_info>
  <brief_title>Attention and Visual Perception</brief_title>
  <official_title>Top-Down Attentional Control of Visual Processing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The NIMH is conducting studies aimed at gaining a better understanding of the areas of the
      brain that are involved in different types of mental processes. This study will focus on
      brain regions involved in visual perception and attention.

      Healthy normal volunteers and people who have had a stroke or undergone neurosurgery may be
      eligible for this study. Candidates must be 18 years of age or older, They must not have a
      history of a psychiatric disorder, including depression, anxiety, psychosis, or neurological
      disease other than stroke or the previous neurosurgery.

      Participants undergo the following tests and procedures during four or more visits to the NIH
      Clinical Center:

        -  Physical and neurological examinations and depression rating scale.

        -  Cognitive testing: Subjects complete written tests, sit at a computer and make decisions
           about what they are shown by pressing keys, or answer questions from a test examiner.

        -  Behavioral training: Subjects practice performing a cognitive task that involves looking
           at and making decisions about visual images that appear on a computer screen.

        -  Magnetic resonance imaging (MRI): Subjects undergo MRI scanning while they perform the
           task they previously practiced. The MRI scanner is a metal cylinder surrounded by a
           strong magnetic field. During the procedure, subjects lie still for up to 10 minutes at
           a time on a table that can slide in and out of the cylinder. The entire MRI scanning
           session takes about one hour. There are multiple scans which each can take up to 10
           minutes. They may be asked to return for one or two additional scanning sessions.

      During the behavioral training or MRI scanning, special pieces of equipment that monitor eye
      movements may be used.

      Some subjects may be asked to return to NIH for an additional visit to participate in a
      magnetoencephalographic scan. This test uses several sensors applied to the scalp to measure
      very small changes in magnetic fields. This is another way to measure brain activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Attention is required for most, if not all, perceptual processes. There is a converging body
      of evidence from single-cell recording studies in monkeys and neuroimaging, behavioral, and
      clinical studies in humans showing that the processing of attended information is enhanced
      relative to the processing of unattended information.

      What is the source of this attentional modulation? Because neuroimaging studies have
      demonstrated that multiple cortical regions are recruited during tasks involving selective
      attention, it has proven difficult thus far to determine the differential contributions of
      each region. A central goal of the proposed research is to characterize the contributions of
      prefrontal cortex and parietal cortex and test the hypothesis that these regions exert
      top-down modulatory influences over visual processing areas. Specifically, we wish to
      investigate the interaction between areas involved in attentional control and visual areas
      modulated by attention.

      We propose to study patients with focal lesions and normal volunteers while they perform
      tasks requiring attention. Subjects will participate, first, in a series of behavioral
      studies involving selective attention; the relative performance of different patient groups
      and neurologically normal volunteers will be compared. Subjects will also be studied while
      performing similar tasks during functional magnetic resonance imaging (fMRI). We hypothesize
      that selective attention will be heavily impaired by lesions of key prefrontal (e.g.,
      dorsolateral prefrontal cortex) and key parietal (e.g., superior parietal lobule) sites. We
      also expect that brain imaging data will show decreased activation in visual regions
      ipsilateral to the focal lesions in prefrontal and parietal cortex, thus providing evidence
      that prefrontal and parietal cortex are sources of top-down modulation. Although other
      research groups have compared the behavior of patients with various focal lesions or have
      performed fMRI studies of visual attention in neurologically normal patients, we are unaware
      of any concerted effort to perform fMRI in patients with focal lesions in order to
      functionally isolate the contributions of individual cortical regions that serve as critical
      nodes in the attentional network.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 16, 2005</start_date>
  <completion_date>May 14, 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">8</enrollment>
  <condition>Focal Lesions</condition>
  <condition>Focal Brain Lesion</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        ALL SUBJECTS -

        All subjects will be volunteers and be 18 years of age or older.

        PATIENTS -

        Subjects with unilateral or bilateral lesions of prefrontal or parietal cortex will be
        selected for participation in the behavioral and brain-imaging studies described within
        this protocol.

        Control subjects with unilateral or bilateral lesions of temporal cortex will also be
        studied.

        Finally, patients with amygdala lesions will also be studied to test the specific
        hypothesis outlined in Experiment 4.

        In order to obtain a sufficient number of focal lesion patients representative of different
        brain regions, patients with different etiologies will be studied, provided the damage is
        circumscribed.

        The main etiologies that we will consider are stroke, lobectomy, and tumor.

        We will restrict groups to include patients with the same etiology, lesion location, and
        lesion volume. Lesion location will consider the two hemispheres separately.

        Patients who also have non-amygdala subcortical lesions will be grouped separately from
        patients with cortical-only lesions.

        Our goal is to not group patients with more focal brain lesions compromising a single
        region (e.g., middle frontal gyrus) with patients with more massive damage (e.g., large
        extents of superior, middle, and inferior frontal gyrus).

        Focal lesion patients will not be excluded on the basis of medication.

        NORMAL VOLUNTEERS -

        Neurologically normal, age-matched volunteers will be recruited from the local community
        through normal Clinical Center channels.

        EXCLUSION CRITERIA:

        The following criteria will be used to exclude patients or healthy volunteers from
        participation in this study:

          -  Patients with language impairments that prevent them from understanding our tasks or
             follow instructions will be excluded.

          -  Patients with a WAIS-R Full-Scale IQ of less than 75 will be excluded.

          -  Patients with severe cognitive dysfunction as assessed by the neuropsychological
             tests.

          -  Subjects with moderate or severe depression as assessed by the Beck Depression
             Inventory (scores greater than 18).

          -  Patients who cannot perform control tasks to the same level of performance as the
             control subjects will be excluded.

          -  Subjects with contraindication to MRI scanning will be excluded from any testing which
             involves the use of MRI. These contraindications include subjects with the following
             devices or conditions: a) central nervous system aneurysm clips; b) implanted neural
             stimulator; c) implanted cardiac pacemaker or defibrillator; d) cochlear implant; e)
             ocular foreign body (e.g., metal shavings); f) insulin pump; g) metal shrapnel or
             bullet; h) any implanted device that is incompatible with MRI.

          -  Subjects with a history of any neurological or psychiatric disorder not related to the
             focal lesion (e.g., epilepsy, schizophrenia, etc.)

          -  Subjects with any previous head injuries not related to the focal lesion.

          -  Subjects with a history of drug or alcohol abuse or addiction (determined by a
             qualified neurologist/psychiatrist).

          -  Subjects with conditions that preclude entry into the scanner (e.g., morbid obesity,
             claustrophobia, etc.) will not be included in brain imaging studies.

          -  Female subjects of child-bearing age will be excluded from brain imaging studies if
             they are pregnant or refuse to undergo a urine pregnancy test.

          -  Subjects with visual, auditory, motor, or language problems that would prohibit them
             from being able to properly perform the visual attention tasks, to understand
             instructions, indicate their responses, or to communicate with the experimenter via an
             intercom system.

          -  Subjects who have undergone radiation treatment or chemotherapy during a one-year
             period prior to the experiment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Anderson AK, Phelps EA. Lesions of the human amygdala impair enhanced perception of emotionally salient events. Nature. 2001 May 17;411(6835):305-9.</citation>
    <PMID>11357132</PMID>
  </reference>
  <reference>
    <citation>Barcel√≥ F, Suwazono S, Knight RT. Prefrontal modulation of visual processing in humans. Nat Neurosci. 2000 Apr;3(4):399-403.</citation>
    <PMID>10725931</PMID>
  </reference>
  <reference>
    <citation>Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex. 2000 Mar;10(3):295-307. Review.</citation>
    <PMID>10731224</PMID>
  </reference>
  <verification_date>May 14, 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2005</study_first_submitted>
  <study_first_submitted_qc>May 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2005</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <keyword>Attention</keyword>
  <keyword>Executive Function</keyword>
  <keyword>Vision</keyword>
  <keyword>fMRI</keyword>
  <keyword>Top-Down</keyword>
  <keyword>Visual Processing</keyword>
  <keyword>Lesion</keyword>
  <keyword>Prefrontal</keyword>
  <keyword>Parietal</keyword>
  <keyword>Focal Brain Lesion</keyword>
  <keyword>Healthy Volunteer</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

